Kelsey McLaughlin

582 total citations
22 papers, 375 citations indexed

About

Kelsey McLaughlin is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Kelsey McLaughlin has authored 22 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Obstetrics and Gynecology, 15 papers in Pediatrics, Perinatology and Child Health and 4 papers in Hematology. Recurrent topics in Kelsey McLaughlin's work include Pregnancy and preeclampsia studies (18 papers), Maternal and fetal healthcare (9 papers) and Birth, Development, and Health (5 papers). Kelsey McLaughlin is often cited by papers focused on Pregnancy and preeclampsia studies (18 papers), Maternal and fetal healthcare (9 papers) and Birth, Development, and Health (5 papers). Kelsey McLaughlin collaborates with scholars based in Canada, United States and United Kingdom. Kelsey McLaughlin's co-authors include John‏ Kingdom, John D. Parker, Melanie C. Audette, Dora Baczyk, Ralph R. Scholten, Tommaso Gori, Michelle Hladunewich, Rory Windrim, Sebastian R. Hobson and Stephen J. Lye and has published in prestigious journals such as Journal of Clinical Oncology, Hypertension and American Journal of Obstetrics and Gynecology.

In The Last Decade

Kelsey McLaughlin

21 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelsey McLaughlin Canada	12	276	216	56	56	36	22	375
Marc Spaanderman Netherlands	10	232 0.8×	175 0.8×	23 0.4×	59 1.1×	16 0.4×	23	347
Mustafa Albayrak Türkiye	12	200 0.7×	129 0.6×	34 0.6×	68 1.2×	6 0.2×	41	403
Oormila Kovilam United States	7	156 0.6×	81 0.4×	18 0.3×	19 0.3×	13 0.4×	12	301
Jean-Claude Forest Canada	5	204 0.7×	167 0.8×	38 0.7×	12 0.2×	6 0.2×	9	331
Sara Pinto France	12	90 0.3×	40 0.2×	38 0.7×	33 0.6×	7 0.2×	32	312
Shital Gandhi Canada	10	156 0.6×	113 0.5×	48 0.9×	29 0.5×	31 0.9×	22	298
Teresa M. MacDonald Australia	14	530 1.9×	397 1.8×	57 1.0×	106 1.9×	7 0.2×	40	666
L.A. Danielson United States	8	215 0.8×	143 0.7×	77 1.4×	48 0.9×	4 0.1×	10	516
Emel Ebru Özçimen Türkiye	13	182 0.7×	86 0.4×	43 0.8×	22 0.4×	5 0.1×	37	400

Countries citing papers authored by Kelsey McLaughlin

Since Specialization

Citations

This map shows the geographic impact of Kelsey McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelsey McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelsey McLaughlin more than expected).

Fields of papers citing papers by Kelsey McLaughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelsey McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelsey McLaughlin. The network helps show where Kelsey McLaughlin may publish in the future.

Co-authorship network of co-authors of Kelsey McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Kelsey McLaughlin. A scholar is included among the top collaborators of Kelsey McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelsey McLaughlin. Kelsey McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gladstone, Rachel A., John W. Snelgrove, Kelsey McLaughlin, et al.. (2025). Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt1): powerful new tools to guide obstetric and medical care in pregnancy. Obstetric Medicine. 18(3). 143–149. 3 indexed citations

Snelgrove, John W., et al.. (2024). Maternal Placental Growth Factor (PlGF) levels, sonographic placental parameters, and outcomes of IVF pregnancies with and without embryo trophectoderm biopsy. Journal of Assisted Reproduction and Genetics. 41(10). 2721–2726.

Malhamé, Isabelle, Kara Nerenberg, Kelsey McLaughlin, et al.. (2024). Hypertensive Disorders and Cardiovascular Severe Maternal Morbidity in the US, 2015-2019. JAMA Network Open. 7(10). e2436478–e2436478. 5 indexed citations

McLaughlin, Kelsey, et al.. (2024). Phenotypes of maternal vascular malperfusion placental pathology and adverse pregnancy outcomes: A retrospective cohort study. BJOG An International Journal of Obstetrics & Gynaecology. 131(11). 1515–1523. 8 indexed citations

McLaughlin, Kelsey, et al.. (2023). Redefining maternal vascular malperfusion (MVM) placental disease by circulating placental growth factor (PlGF) level. American Journal of Obstetrics and Gynecology. 228(1). S728–S729. 2 indexed citations

Audette, Melanie C., Kelsey McLaughlin, & John‏ Kingdom. (2021). Second Trimester Placental Growth Factor Levels and Placental Histopathology in Low-Risk Nulliparous Pregnancies. Journal of Obstetrics and Gynaecology Canada. 43(10). 1145–1152.e1. 8 indexed citations

McLaughlin, Kelsey, John W. Snelgrove, Melanie C. Audette, et al.. (2021). PlGF (Placental Growth Factor) Testing in Clinical Practice: Evidence From a Canadian Tertiary Maternity Referral Center. Hypertension. 77(6). 2057–2065. 42 indexed citations

McLaughlin, Kelsey, Sebastian R. Hobson, Anjana Chandran, et al.. (2021). Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction. American Journal of Obstetrics and Gynecology. 226(2). S1145–S1156.e1. 30 indexed citations

Doherty, Anne M., Kelsey McLaughlin, & John‏ Kingdom. (2020). Hemodynamic Complications in Pregnancy. Clinics in Perinatology. 47(3). 653–670. 9 indexed citations

10.

McLaughlin, Kelsey, et al.. (2020). Low molecular weight heparin promotes transcription and release of placental growth factor from endothelial cells. American Journal of Physiology-Heart and Circulatory Physiology. 318(4). H1008–H1017. 14 indexed citations

11.

McLaughlin, Kelsey, Melanie C. Audette, John D. Parker, & John‏ Kingdom. (2018). Mechanisms and Clinical Significance of Endothelial Dysfunction in High-Risk Pregnancies. Canadian Journal of Cardiology. 34(4). 371–380. 20 indexed citations

12.

McLaughlin, Kelsey, Jianhong Zhang, Stephen J. Lye, John D. Parker, & John‏ Kingdom. (2018). Phenotypes of Pregnant Women Who Subsequently Develop Hypertension in Pregnancy. Journal of the American Heart Association. 7(14). 29 indexed citations

13.

McLaughlin, Kelsey, Stephen P. Wright, John‏ Kingdom, & John D. Parker. (2017). Clinical Validation of Non-Invasive Cardiac Output Monitoring in Healthy Pregnant Women. Journal of Obstetrics and Gynaecology Canada. 39(11). 1008–1014. 11 indexed citations

14.

McLaughlin, Kelsey, Ralph R. Scholten, John D. Parker, E. Ferrazzi, & John‏ Kingdom. (2017). Low molecular weight heparin for the prevention of severe preeclampsia: where next?. British Journal of Clinical Pharmacology. 84(4). 673–678. 21 indexed citations

15.

McLaughlin, Kelsey, et al.. (2016). Low Molecular Weight Heparin Improves Endothelial Function in Pregnant Women at High Risk of Preeclampsia. Hypertension. 69(1). 180–188. 49 indexed citations

16.

McLaughlin, Kelsey, Sascha Drewlo, John D. Parker, & John‏ Kingdom. (2015). Current Theories on the Prevention of Severe Preeclampsia With Low-Molecular Weight Heparin. Hypertension. 66(6). 1098–1103. 23 indexed citations

17.

McLaughlin, Kelsey, et al.. (2014). Repeated daily dosing with sildenafil provides sustained protection from endothelial dysfunction caused by ischemia and reperfusion: a human in vivo study. American Journal of Physiology-Heart and Circulatory Physiology. 307(6). H888–H894. 19 indexed citations

18.

McLaughlin, Kelsey, et al.. (2013). Daily Ischemic Preconditioning Provides Sustained Protection From Ischemia–Reperfusion Induced Endothelial Dysfunction: A Human Study. Journal of the American Heart Association. 2(1). e000075–e000075. 32 indexed citations

19.

Musselman, Reilly, et al.. (2012). Should lymph node retrieval be a surgical quality indicator in colon cancer?. Journal of Clinical Oncology. 30(4_suppl). 648–648. 2 indexed citations

20.

James, IM, et al.. (1992). Blood pressure lowering and cerebral blood flow: a comparison of the effects of carvedilol and propranolol on the cerebral circulation in hypertensive patients.. PubMed. 19 Suppl 1. S40–3. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact